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Background: Patients undergo coronary artery bypass graft (CABG) surgery soon after thienopyridine discontinuation despite guideline 
recommendations. We aimed to evaluate the value of on-treatment platelet reactivity testing before CABG in the prediction of in-hospital major 
bleeding (IHMB).
Methods: On-treatment platelet reactivity was measured with Verify Now (VN) P2Y12 assay, Vasodilator Stimulated Phosphoprotein Phosphorylation 
(VASP) and Light Transmittance Aggregometry (LTA) with 5 and 20 μM of ADP. Patients undergoing CABG within 5 days of thienopyridine 
discontinuation from 08/2010 to 10/2011 were included. IHMB was defined as bleeding intracranially or that associated with hemodynamic 
compromise, a hemoglobin (Hb) drop of > 5g/dl, or a hematocrit drop of >15%. The relation of platelet reactivity value and IHMB was assessed with 
Wilcoxon rank-sum test. Its relation with Hb drop with Spearman correlation.
Results: 67 patients were evaluated and IHMB occurred in 32 (47.8%). VASP and LTA with 5 and 20 μM of ADP were associated with IHMB. (Table) 
Cutoff values of 235 P2Y12 reaction units (PRU) for VN and 50% PRI for VASP were not predictive of IHMB. VN PRU was inversely correlated to the 
degree of Hb drop after CABG (p= 0.007).
Conclusion: Only platelet reactivity testing with VASP and LTA 5 and 20 μM of ADP before CABG is associated with subsequent IHMB.
These tests could be used to risk stratify patients undergoing CABG after thienopyridine discontinuation. 
Major bleeding present (Median [IQ range]) Major bleeding absent (Median [IQ range]) p Value
Verify Now (PRU) 203.5 [173.5-303.5] 225.5 [191-299] 0.282
VASP (PRI ) 56.7 [25-65.4] 68.7 [52.5-76.5] 0.004
LTA ADP 5μM 39 [31-51] 48 [42-57] 0.018
LTA ADP 20μM 50 [43-65] 63.5 [50-72] 0.015
Correlation of PRU by Verify Now and Hb drop
